Main / Blog / 🩺 Non-Invasive Infection Screening: How Kriba Turns Serous-Fluid Signals into Decisions

Blog

🩺 Non-Invasive Infection Screening: How Kriba Turns Serous-Fluid Signals into Decisions

Serge

October 28, 2025

Share:

Serge

October 28, 2025

Share:

I met the Kriba team at Web Summit 2024, and their focus was razor-sharp: detect infections in serous fluids non-invasively and fast—so clinicians act earlier and patients avoid painful, risky procedures.

🧩 The Problem: Infections Hide in Plain Sight

Newborn meningitis, PD-associated peritonitis, and ocular uveitis demand speed and precision, yet today’s workflows often require invasive sampling, trained specialists, and time. That delays decisions and drives cost. Kriba frames this as an access and accuracy gap.

šŸ”§ The Solution: Ultrasound + AI, No Needle Required

Kriba’s NeosonicsĀ® platform non-invasively estimates white blood cell counts in serous fluids (e.g., CSF via the fontanelle, dialysis effluent, anterior chamber) using high-resolution ultrasound and deep-learning analysis—in under a minute. (Device under investigation; not for sale.)

  • Newborns: transfontanellar WBC counter to reduce negative lumbar punctures.
  • Kidney care: automatic WBC screening on peritoneal dialysis drainage bags.
  • Eye care: non-invasive uveitis screening and monitoring behind the cornea.

Peer-reviewed work from the team shows an in-vitro ultrasound platform for infant meningitis detection, signalling solid R&D momentum.

šŸš€ What Makes Kriba Different

  • First-in-class WBC screening, non-invasively across multiple serous fluids.
  • Mission for global access: affordable, quick tools to democratise diagnostics.
  • Clear trajectory: rebrand from Newborn Solutions → Kriba to scale toward CE marking.

šŸ‘„ Team & Links

Led by Javier JimĆ©nez (CEO), with FabiĆ£o Santos (R&D Lab Director), Hassane Baghdad Kichou (R&D Electronics Eng. Director), and Manuel Navarrete (Firmware Eng.)—the mix spans clinical research, electronics, and embedded systems. See the full team: kriba.ai/team. Connect via Kriba on LinkedIn.

šŸ¤ YOUR R&D: Collaboration Paths for Non-Invasive Diagnostics

  • Data & ML pipelines: secure ingestion, labeling, and validation for ultrasound-AI; drift/bias monitoring; audit trails.
  • Clinical software & interop: imaging viewers, structured reports, and FHIR connectors to EHRs/registries.
  • Regulatory tooling: traceability, SBOMs, risk files; support toward CE/FDA evidence packages.
  • Edge deployment: optimized inference on portable probes/gateways with offline-first design and robust QA.

Curious about our methods? Start with the YOUR R&D blog

āœ… Conclusion

Kriba is building a needle-free, AI-assisted screening layer for infections that clinicians struggle to catch early—spanning neonatology, nephrology, and eye care. If you’re evaluating non-invasive diagnostics with real-world constraints, keep an eye on kriba.ai.


#MedTech #HealthTech #AIinHealthcare #Ultrasound #DigitalDiagnostics #SoftwareDevelopment #Innovation


You might be interested in